Explore the compelling links between the Endocannabinoid System (ECS) and Autism Spectrum Disorders (ASD). This in-depth review delves into genetic and chemically-induced in vivo models, ECS biomarkers in ASD, and the latest clinical research on ECS-targeted interventions. Understand the ECS’s role as a potential therapeutic target and its broader implications for ASD pathology and treatment.
This comprehensive review delves into the genetic intricacies of the Endocannabinoid System (ECS) or Master Homeostatic Regulatory System (MHRS), illuminating its pivotal role in physiological homeostasis and its susceptibility to genetic mutations. By exploring the impact of these variations on behavior and disease, the article aims to serve as a foundation for future research and therapeutic developments in this burgeoning field.